ImClone Systems Incorporated - Financial and Strategic Analysis Review

Summary

ImClone Systems Incorporated - Financial and Strategic Analysis Review

Summary

ImClone Systems Incorporated (ImClone), a biopharmaceutical company, is engaged in the research and development of oncology methodologies and therapies. The company keenly focuses on growth factor blockers and angiogenesis inhibitors. The trademark product of ImClone is Erbitux, a type of therapeutic monoclonal antibody. As on November 24, 2008, the company was acquired by Eli Lilly and Company and it has become a wholly owned subsidiary of Eli Lilly. The company is headquartered at New York, the US and operates in two locations in the US

Global Markets Direct's ImClone Systems Incorporated - Financial and Strategic Analysis Review is an in-depth business, strategic and financial analysis of ImClone Systems Incorporated. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.

Scope

• Provides key company information for business intelligence needs.
• The company's strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
• The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
• The report contains critical company information - business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
• The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
• Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Reasons to buy

• A quick "one-stop-shop" to understand the company.
• Enhance business/sales activities by understanding customers' businesses better.
• Get detailed information and financial and strategic analysis on companies operating in your industry.
• Identify prospective partners and suppliers - with key data on their businesses and locations.
• Capitalize on competitor's weaknesses and target the market opportunities available to them.
• Compare your company's financial trends with those of your peers / competitors.
• Scout for potential acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Contents

• List of Tables
• List of Figures
  • ImClone Systems Incorporated - Key Facts
  • ImClone Systems Incorporated - Business Description
  • ImClone Systems Incorporated - Major Products and Services
  • ImClone Systems Incorporated - History
  • ImClone Systems Incorporated - SWOT Analysis
  • SWOT Analysis - Overview
  • ImClone Systems Incorporated - Strengths
  • Strength - Strong Research and Development Activities
  • Strength - Performance of Erbitux
  • Strength - Robust Manufacturing facility
  • ImClone Systems Incorporated - Weaknesses
  • Weakness - Termination of Agreement
  • Weakness - Patent Litigation
  • ImClone Systems Incorporated - Opportunities
  • Opportunity - Expansion of Erbitux
  • Opportunity - Ageing Population
  • Opportunity - Launch of ERBITUX in Canada and Japan
  • Opportunity - Acquisition by Eli Lilly
  • Opportunity - Changing Demographics
  • ImClone Systems Incorporated - Threats
  • Threat - Broad Market coverage of Vectibix
  • Threat - Competitive Environment
  • Threat - Reimbursement of Newly Approved Products
  • Threat - Complex Regulatory Approvals
  • ImClone Systems Incorporated - Key Competitors
  • ImClone Systems Incorporated - Key Employees
  • ImClone Systems Incorporated - Key Employee Biographies
  • ImClone Systems Incorporated - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • ImClone Systems Incorporated - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
  • Appendix
  • Methodology
  • Ratio Definitions
  • About Global Markets Direct
  • Contact Us
  • Disclaimer
• List of Tables
  • ImClone Systems Incorporated, Key Facts
  • ImClone Systems Incorporated, History
  • ImClone Systems Incorporated, Key Employees
  • ImClone Systems Incorporated, Key Employee Biographies
  • ImClone Systems Incorporated, Other Locations
  • ImClone Systems Incorporated, Ratios based on current share price
  • ImClone Systems Incorporated, Annual Ratios
  • ImClone Systems Incorporated, Interim Ratios
• List of Figures
  • ImClone Systems Incorporated, Ratio Charts